Low numbers of blood and salivary natural killer cells are associated with a better response to belimumab in primary Sjögren’s syndrome: results of the BELISS study

INTRODUCTION: In this study, we sought to address changes in blood lymphocyte subpopulations and labial salivary gland (LSG) inflammation after belimumab treatment in patients with primary Sjögren’s syndrome (pSS) and to identify predictors of response to treatment. METHODS: Sequential blood lymphoc...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Arthritis Res Ther
Autori principali: Seror, Raphaèle, Nocturne, Gaétane, Lazure, Thierry, Hendel-Chavez, Houria, Desmoulins, Frédéric, Belkhir, Rakiba, Ravaud, Philippe, Benbijja, Mohcine, Poirier-Colame, Vichnou, Taoufik, Yacine, Mariette, Xavier
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2015
Soggetti:
Research Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4559969/
https://ncbi.nlm.nih.gov/pubmed/26336930
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13075-015-0750-y
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi